Premium
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive‐compulsive disorder
Author(s) -
Storch Eric A.,
Lehmkuhl Heather,
Geffken Gary R.,
Touchton Alexis,
Murphy Tanya K.
Publication year - 2008
Publication title -
depression and anxiety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.634
H-Index - 129
eISSN - 1520-6394
pISSN - 1091-4269
DOI - 10.1002/da.20303
Subject(s) - aripiprazole , sertraline , psychology , obsessive compulsive , exposure and response prevention , cognitive behavioral therapy , clinical psychology , psychiatry , cognition , psychotherapist , medicine , schizophrenia (object oriented programming) , antidepressant , anxiety
We report the case of adolescent male with obsessive‐compulsive disorder (OCD) who had an incomplete response to combined cognitive‐behavioral therapy (CBT) and sertraline before successful augmentation of CBT with aripiprazole. Standardized assessments indicated significant reductions in OCD symptomatology associated with both initial treatment and aripiprazole augmentation. This case suggests that aripiprazole may have utility as an augmenting agent of CBT in adolescents with OCD and underscores the need for conducting controlled studies to test this hypothesis. Depression and Anxiety 25:172–174, 2008. © 2008 Wiley‐Liss, Inc.